Embla Medical hfOSSFF 92 Quick Ratio is 0.76 as of Mar. 2026, which is 38% below its 10-year median of 1.22. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.49. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Embla Medical hf ranks worse than 85.6% on this metric.
Embla Medical hf has a quick ratio of 0.76. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Embla Medical hf's Quick Ratio or its related term are showing as below:
OSSFF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.58 Med: 1.22 Max: 1.96
Current: 0.76
During the past 13 years, Embla Medical hf's highest Quick Ratio was 1.96. The lowest was 0.58. And the median was 1.22.
OSSFF's Quick Ratio is ranked worse than 85.6% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs OSSFF: 0.76
Embla Medical hf (OTCPK:OSSFF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Embla Medical hf Quick Ratio Related Terms
Embla Medical hf Quick Ratio Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Embla Medical hf's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OSSFF) has a Quick Ratio of 0.76 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Embla Medical hf and its competitors. This is 38% below median its historical median of 1.22. Over the past decade, Embla Medical hf's Quick Ratio has ranged from 0.58 to 1.96. According to the industry distribution chart, Embla Medical hf ranks #731 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 85.6%.
Is Embla Medical hf's Quick Ratio too high?
Embla Medical hf's current Quick Ratio of 0.76 is 38% below median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 1.96. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Embla Medical hf's value of 0.76 is 59.2% below this industry median. Based on the distribution chart, Embla Medical hf ranks #731 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #731 out of 854 companies for Quick Ratio. This places Embla Medical hf in the lower half of its industry. The industry median Quick Ratio is 1.87. Embla Medical hf's value of 0.76 is 59.2% below this benchmark. Historically, Embla Medical hf's own Quick Ratio has ranged from 0.58 to 1.96 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 1.87, Embla Medical hf has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Quick Ratio of 0.76 is 59.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Quick Ratio is 0.76, which is 38% below median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Quick Ratio of 0.76. The stock's GF Value™ is $5.49, compared to a current price of $4.15 — trading 24.4% below its estimated fair value. The current Quick Ratio is 0.76, which is 38% below median its 10-year median of 1.22 and 59.2% below the Medical Devices & Instruments industry median of 1.87. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Quick Ratio is 0.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 24.4% below its estimated GF Value™ of $5.49.
Key valuation signals for OSSFF:
Quick Ratio: 0.76 (38% below median its 10-year median of 1.22)
GF Value™: $5.49 vs. price of $4.15 (24.4% below fair value)
Industry Position: 59.2% below the Medical Devices & Instruments median (#731 of 854)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
